ROANOKE, Va. (WDBJ) - Dr. Carlos Mora in Carilion Clinic’s Department of Neurology has seen a change as comparable as night and day when it comes to treatment for Multiple Sclerosis. Mora said when he ...

After decades of effort, scientists have made real progress in understanding multiple sclerosis. While researchers long knew it was an autoimmune disorder that damages the myelin sheath that serves to ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

We know so much more about multiple sclerosis (MS) than we used to. But one important theme is that we’ve become much better at treating the relapsing form of this disease and changing its natural ...

Synaptic injury in the IPL of the retina is linked to MS progression, with IPL thickness as a potential biomarker. Hypoxia in MS patients exacerbates inflammation and mitochondrial damage, ...

In older people with MS, having fatigue and limited leg function is more often seen in people with MS progression than in those without, according to a preliminary study released today that will be ...

The Breakthrough Prize has announced its 2025 Laureates in Life Sciences, Fundamental Physics, and Mathematics. Among them are Professors Alberto Ascherio from Harvard University and Stephen Hauser ...

NEW HAVEN, Conn. (WTNH) — Multiple sclerosis is a lifelong condition, but there are new ways to manage it. MS affects the central nervous system. However, groundbreaking options can bring some hope.

The Epstein-Barr virus (EBV) is our constant companion, infecting an estimated 90%-95% of adults. Many of us are first infected as children, when the germ may trigger cold and flu symptoms. EBV also ...

Share on Pinterest Can ancient bodies reveal some of the secrets of multiple sclerosis? Design by MNT: Photography by ER Productions Limited/Getty Images & DEA PICTURE LIBRARY/Getty Images. Multiple ...

Multiple sclerosis (MS) is recognized as one of the most prevalent neurological diseases among young adults, with symptoms typically emerging between ages 20 to 40 years. The condition is ...